My Profile e-Learning Center my.ASTHO Contact Us

Filter Results

Clear All Filters

Topic

Product Type

Contributor

Published Date

Displaying 3 results for

GO
Search Filters: COVID and Communication cancel Vaccine Hesitancy cancel Vaccine Distribution cancel COVID and Law/Policy cancel Immunization cancel

A Public Health Milestone: COVID-19 Vaccine Q&A With Meredith Allen, ASTHO’s Vice President for Health Security

Blog,
People of Public Health,
Infectious Disease,
COVID-19,
COVID Vaccine,
COVID and Communication,
COVID and Capacity,
COVID and Law/Policy,
COVID and Health Equity/Health Disparities,
Health Equity,
At-Risk Populations,
Partnership,
Immunization,
Vaccine Distribution,
Vaccine Hesitancy,
Leadership and Workforce Development,
Preparedness,
Pandemics,
Research,
Meredith Allen,
Communications,
Leadership Development

A discussion with Meredith Allen, ASTHO’s Vice President for Health Security, about how the first shipments of the COVID-19 vaccinations have been a major turning point for the pandemic and a milestone moment for U.S. public health ...

FDA’s Approval of the Pfizer-BioNTech COVID-19 Vaccine: Five Things to Know

Infectious Disease,
COVID-19,
COVID Vaccine,
COVID and Communication,
Immunization,
Vaccine Distribution,
Vaccine Hesitancy,
Emerging Infectious Diseases,
Policy,
Federal Government Affairs,
Blog,
Preparedness,
Meredith Allen,
COVID and Law/Policy

On Aug. 23, 2021, the FDA announced full approval of Pfizer and BioNTech’s mRNA vaccine for COVID-19. ASTHO has answers to five key questions about the approval and what it means for state and territorial health officials: What does the ...

What You Need to Know About the COVID-19 Vaccine

Blog,
Health Policy Update,
Infectious Disease,
COVID-19,
COVID Vaccine,
COVID and Healthcare Systems,
COVID and Law/Policy,
Policy,
Federal Government Affairs,
COVID and Communication,
Immunization,
Vaccine Distribution,
Vaccine Hesitancy,
Preparedness,
Pandemics,
Public Health Infrastructure and Systems Improvement,
Public Health Infrastructure and Systems Improvement,
Accreditation,
Emma Lange

Many pharmaceutical companies urgently began developing a COVID-19 vaccine earlier this year to reduce the spread of the virus as the threat of a pandemic loomed. Fast forward several months and millions of COVID-19 cases later, states and ...